CD93 a potential player in cytotrophoblast and endothelial cell migration

被引:17
|
作者
Fantone, Sonia [1 ]
Tossetta, Giovanni [1 ,2 ,3 ]
Di Simone, Nicoletta [4 ]
Tersigni, Chiara [5 ,6 ]
Scambia, Giovanni [5 ,6 ]
Marcheggiani, Fabio [7 ]
Giannubilo, Stefano R. [2 ]
Marzioni, Daniela [1 ]
机构
[1] Univ Politecn Marche, Dept Expt & Clin Med, I-60126 Ancona, Italy
[2] Univ Politecn Marche, Azienda Osped Univ, Salesi Hosp, Dept Clin Sci, Ancona, Italy
[3] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20072 Milan, Italy
[4] Humanitas Res Hosp, IRCCS, Via Manzoni 56, Milan, Italy
[5] Fdn Policlin Univ A Gemelli IRCCS, OUC Ostetricia Patol Ostetr, Dipartimento Sci Salute Donna, Bambino Sanita Pubbl, I-00168 Rome, Italy
[6] Univ Cattolica Sacro Cuore, Ist Clin Ostetr Ginecol, I-00168 Rome, Italy
[7] Univ Politecn Marche, Dept Life & Environm Sci, I-60131 Ancona, Italy
关键词
Preeclampsia (PE); CD93; Complement component C1q receptor; Placenta; Angiogenesis; IN-VITRO; TROPHOBLAST; ANGIOGENESIS; EXPRESSION; INVASION; SURFACE; ADHESION; RECEPTOR; C1QR(P);
D O I
10.1007/s00441-021-03543-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD93, also known as complement component C1q receptor, is expressed on the surface of different cellular types such as monocytes, neutrophils, platelets, microglia, and endothelial cells, and it plays a pivotal role in cell proliferation, cell migration, and formation of capillary-like structures. These processes are strictly regulated, and many fetal and maternal players are involved during placental development. At present, there are no studies in literature regarding CD93 in placental development, so we investigated CD93 expression in first and third trimester and PE placentas by immunohistochemistry and western blotting analysis. In addition, we performed in vitro experiments under oxidative stress conditions to demonstrate how oxidative stress acts on CD93 protein expression. Our data showed that CD93 was expressed in villous cytotrophoblast cells, in some fetal vessels of first and third trimester and PE placentas and in the extravillous cytotrophoblast of cell columns in the first trimester placentas. Moreover, we detected a significant decrease of CD93 expression in third trimester and PE placentas compared to first trimester placentas, while no differences were detected between third and PE placentas. No differences of CD93 expression were detected in oxidative stress conditions. We suggest that CD93 can guide extravillous cytotrophoblast migration through beta 1-integrin in uterine spiral arteries during placentation in the first trimester of pregnancy and that the decrease of CD93 expression in third trimester and PE placentas could be linked to the poor extravillous cytotrophoblast cells migration. So, it might be interesting to understand the role of CD93 in the first phases of PE onset.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 50 条
  • [1] CD93 a potential player in cytotrophoblast and endothelial cell migration
    Sonia Fantone
    Giovanni Tossetta
    Nicoletta Di Simone
    Chiara Tersigni
    Giovanni Scambia
    Fabio Marcheggiani
    Stefano R. Giannubilo
    Daniela Marzioni
    Cell and Tissue Research, 2022, 387 : 123 - 130
  • [2] CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration
    Galvagni, Federico
    Nardi, Federica
    Maida, Marco
    Bernardini, Giulia
    Vannuccini, Silvia
    Petraglia, Felice
    Santucci, Annalisa
    Orlandini, Maurizio
    ONCOTARGET, 2016, 7 (09) : 10090 - 10103
  • [3] The C-type lectin CD93 controls endothelial cell migration via activation of the Rho family of small GTPases
    Barbera, Stefano
    Lugano, Roberta
    Pedalina, Alessia
    Mongiat, Maurizio
    Santucci, Annalisa
    Tosi, Gian Marco
    Dimberg, Anna
    Galvagni, Federico
    Orlandini, Maurizio
    MATRIX BIOLOGY, 2021, 99 : 1 - 17
  • [4] Role of CD93 in Health and Disease
    Tossetta, Giovanni
    Piani, Federica
    Borghi, Claudio
    Marzioni, Daniela
    CELLS, 2023, 12 (13)
  • [5] Soluble CD93 is an apoptotic cell opsonin recognized by αxβ2
    Blackburn, Jack W. D.
    Lau, Darius H. C.
    Liu, Elaine Y.
    Ellins, Jessica
    Vrieze, Angela M.
    Pawlak, Emily N.
    Dikeakos, Jimmy D.
    Heit, Bryan
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (04) : 600 - 610
  • [6] CD93 as a Potential Target in Neovascular Age-Related Macular Degeneration
    Tosi, Gian Marco
    Caldi, Elena
    Parolini, Barbara
    Toti, Paolo
    Neri, Giovanni
    Nardi, Federica
    Traversi, Claudio
    Cevenini, Gabriele
    Marigliani, Davide
    Nuti, Elisabetta
    Bacci, Tommaso
    Galvagni, Federico
    Orlandini, Maurizio
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (07) : 1767 - 1773
  • [7] The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target
    Orlandini, Maurizio
    Galvagni, Federico
    Bardelli, Monia
    Rocchigiani, Marina
    Lentucci, Claudia
    Anselmi, Francesca
    Zippo, Alessio
    Bini, Luca
    Oliviero, Salvatore
    ONCOTARGET, 2014, 5 (09) : 2750 - 2760
  • [8] Soluble CD93 in allergic asthma
    Park, Hye Jung
    Oh, Eun-Yi
    Han, Hee-Jae
    Park, Kyung Hee
    Jeong, Kyoung-Yong
    Park, Jung-Won
    Lee, Jae-Hyun
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [9] Plasma CD93 concentration is a potential novel biomarker for coronary artery disease
    Malarstig, A.
    Silveira, A.
    Wagsater, D.
    Ohrvik, J.
    Backlund, A.
    Samnegard, A.
    Khademi, M.
    Hellenius, M. -L.
    Leander, K.
    Olsson, T.
    Uhlen, M.
    de Faire, U.
    Eriksson, P.
    Hamsten, A.
    JOURNAL OF INTERNAL MEDICINE, 2011, 270 (03) : 229 - 236
  • [10] CD93 maintains endothelial barrier function and limits metastatic dissemination
    Vemuri, Kalyani
    Pereira, Beatriz de Alves
    Fuenzalida, Patricia
    Subashi, Yelin
    Barbera, Stefano
    van Hooren, Luuk
    Hedlund, Marie
    Ponten, Fredrik
    Lindskog, Cecilia
    Olsson, Anna-Karin
    Lugano, Roberta
    Dimberg, Anna
    JCI INSIGHT, 2024, 9 (07)